01 Contipro a.s. Dolní Dobrouč CZ (1)
01 Sodium hyaluronate, Intrinsic viscosity: not less than 0.65 m3/kg; by fermentation, for parenteral administration including intra-articular use and intra-ocular use (1)
01 Czech Republic (1)
01 Valid (1)
20
Contipro A.s. Dolní Dobrouč Cz, based in Czech Republic, is a pharmaceutical company.
One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity: not less than 0.65 m3/kg; by fermentation, for parenteral administration including intra-articular use and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-194 - Rev 03
This Chemical Type CEP, issued on May 10, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1472 associated with this CEP further emphasizes